Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 39 for “"TZD"”.
-
The influence of newly synthesized hybrid Thiazolidinedione (TZD)-methoxy on the expression and acetylation of diabetes related genes
… kit to establish an optimal Thiazolidinedione (TZD) concentration to be used in these cells. There were five treatment groups in this study, namely, control (normal), palmitate (to induce insulin resistance) , palmitate + metformin, palmitate + TZD and TZD only. Complementary Deoxyribonucleic …
-
Improving the function of islet and beta-cell grafts
… and the effect of a thiazolidinedione (TZD) on DII function and HUVEC proliferation. To assess the effect of culture media, SC, RC and a TZD on human islet morphology, insulin secretion and VEGF production. To initiate in vivo protocol development for assessment of revascularisation of …
-
A Pharmacovigilance Approach for Assessing Cardiovascular, Osteological, and Carcinogenic Risk Associated with Thiazolidinedione Drugs Used in the Treatment of Type 2 Diabetes Mellitus
… blood sugar levels. The thiazolidinedione (TZD) class of drugs consists of oral hypoglycaemic agents used alone or in combination with other antidiabetic drugs to treat T2DM. The drugs within this class, which include rosiglitazone and pioglitazone, were originally heralded as providing …
-
Effects Of Modified Insulin Resistance On Glucose And Fatty Acid Metabolism During Late Gestation In Dairy Cattle
… sensitizing agent (2,4-thiazolidinedione; TZD) and plane of nutrition (PON) can affect the metabolic health of transition cows. In experiment one, plasma leptin and tumor necrosis factor-[alpha], and adipose tissue peroxisome proliferator activated-[gamma] (PPAR[gamma]) mRNA were increased …
-
Pharmacological modulation of insulin resistance - benefits and harms
… with T2DM ‘tolerant’ or ‘intolerant’ of TZDs; (ii) risk factors for TZD-associated oedema in T2DM; and (iii) the potential for metformin as adjunct therapy in T1DM.<br/><br/>Methods: (i) A small clinical study characterising TZD tolerant and intolerant<br/>individuals with T2DM; (ii) A …
-
Development of adverse outcome pathways framework for the identification of novel mechanistic and clinical insights into the cardiotoxic actions of thiazolidinediones
… disease management. Thiazolidinediones (TZDs), represented by pioglitazone and rosiglitazone, are a class of cost-effective oral anti-diabetic agents that pose a marginal hypoglycaemia risk. While TZDs initially demonstrated efficacy in maintaining glycaemic control, safety concerns, …
-
Evaluation of the impact of cardiovascular safety concerns of thiazolidinediones on the utilization of oral antidiabetic drugs
… on the utilization of the thiazolidinediones (TZDs), pioglitazone and rosiglitazone, and other oral antidiabetic drugs. In May 2007, a meta-analysis was published that found a potential increased risk of myocardial infarction (MI) associated with TZDs, particularly with rosiglitazone. A …
-
Macrophage PPAR-Gamma Inhibits Gpr132 to Mediate the Anti-Tumor Effects of Rosiglitazone
… and inhibited by the thiazolidinedione (TZD) class of synthetic PPARgamma agonists and type 2 diabetes drugs such as rosiglitazone. However, it remains enigmatic whether and how macrophage contributes to PPARgamma tumor-suppressive functions. Here we uncover that macrophage PPARgamma …
-
Concurrent Adherence To Multiple Chronic Disease Medications: Examining The Behavior And Issues Concerning Its Measurement
… both sulfonylurea (su) and thiazolidinedione (tzd). Adherence was measured by proportion of days covered (pdc) over each period of 30 or 90 days and cumulatively. Random components from multivariate multilevel models were analyzed to examine multiple medication adherence relationships, …
-
Neuroprotective and immunomodulatory properties of the new PPARγ agonist MDG548: an in vitro and in vivo study in PD models
… raised about PPARγ agonists thiazolidinediones (TZD) currently available, prompting for the development of non-TZD compounds. Aim of this study was to characterize a novel PPARγ agonist non TZD, MDG548, for its potential neuroprotective effect in PD models and its immunomodulatory activity as the …
-
Phenotypic and Genotypic Determinants of Drug Response to Anti-Hyperglycaemic Drugs in White Europeans and Asian Indians
… response to treatment with DPP-4I, SU and TZD in T2D individuals from Tayside and Fife, Scotland, Madras Diabetes Research Foundation (MDRF), India and UKBB populations. We assessed whether anthropometric, clinical and biochemical factors including markers of insulin resistance and insulin …
-
Role of Galactose, Thiazolidinediones, and NEET proteins in Mitochondrial physiology and therapeutic development.
… the relationship between the thiazolidinedione (TZD) class of drugs and mitochondrial physiology. I characterize the effects of a classical TZD (pioglitazone) and two experimental TZDs (NL-1 and NL-2) on mitochondrial bioenergetics in cells derived from mammalian liver, muscle, and adipose …
-
The Association Between Oral Glucose-Control Agents and Incident Dementia in Type 2 Diabetes Within the Veteran’s Affairs Healthcare Enrollees
… sulfonylureas [SU], and thiazolidinedione [TZD]) with the risk of dementia. And study 2 compared the associations of adding dipeptidyl peptidase-4 inhibitors (DPP-4is) to MET and/or SU (MET/SU) treatment with risks of dementia and other vascular events. To capture the trends of clinical …
-
Understanding Molecular Interactions: Application of HINT-based Tools in the Structural Modeling of Novel Anticancer and Antiviral Targets, and in Protein-Protein Docking
… of an isoform selective thiazolidine-2,4-dione (TZD) analog; ii) structural modeling of human cytomegalorvirus (HCMV) alkaline nuclease (AN) UL98 (a novel antiviral target) and subsequent virtual screening of its active site; and iii) explicit treatment of interfacial waters during …
-
Valutazione dell'attività antinfiammmatoria /antidegenerativa
… il processo osteoartritico: i tiazolidinoni (TZD). I TZD rappresentano una classe di composti ampliamente studiata per le loro proprietà farmacologiche, essi hanno mostrato di possedere un ampia varietà di attività biologiche ed oggi sono utilizzati nella cura del diabete come …
-
Functional genomic analysis of PPAR-gamma in human colorectal cancer cells
… Activation of PPAR-gamma by thiazolidinediones (TZDs) inhibits proliferation and induces differentiation in human colon cancer cells. RS5444, a novel TZD, is a high affinity and high specificity ligand for PPAR-gamma. We have shown that RS5444 markedly reduced the proliferation of MOSER S human …
-
Co-Transcriptional Splicing and Functional Role of PKCβ in Insulin-Sensitive L6 Skeletal Muscle Cells and 3T3-L1 Adipocytes
… correlate with human insulin resistance. TZD treatment ameliorates whole-body insulin-resistance. Its primary target is adipocyte PPAR γ, which it activates upon binding. This causes both altered circulating serum FFA concentrations and adipokine secretion profile. How TZDs affect the …
-
Comparison of In-Vehicle Technologies with Traditional Safety Measures to Prevent Crashes along Curves and Shoulders
… this cost-effectiveness. · Contribution to TZD – The state expends a fixed amount of safety budget every year. Thus, given a fixed amount of money, the treatment giving the most reduced number of fatalities was evaluated. This was defined as the deployment factor. The treatment having the …
-
Defining Novel Clusters of PPAR gamma Partial Agonists for Virtual Screening
… 2 diabetes mellitus (T2D). Thiazolidinediones (TZDs) are agonists of PPARγ which have an insulin sensitizing effect, and are therefore used as a treatment for T2D. However, TZDs cause negative side effects in patients, such as weight gain, edema, and increased risk of bone fracture. Partial …
-
Regulation of Phosphorylation of PPARγ by CDK5 in Obesity
PPAR? is the receptor for thiazolidinedione (TZD) anti-diabetes drugs, and a key regulator of adipose differentiation and insulin sensitivity. Increased heart failure associated with specific TZDs has reduced their clinical use. However recent work suggested that phosphorylation of PPAR? at Ser273 …
Page 1 of 2